In this study, we found that TMPRSS4 promoted cancer stem–like properties such as tumorsphere formation, ALDH activation, drug resistance, and anoikis resistance, and subsequent early metastasis (circulating tumor cell (CTC) survival) in prostate cancer cells and upregulated stemness-related markers including SOX2. Here, SOX2 is linked to prostate carcinoma.